Quintiles and the University of North Carolina at Chapel Hill are team up for a clinical research alliance.

To help jumpstart the alliance, Quintiles is providing UNC with a $600,000 grant.

“This is a highly creative, innovative partnership between a leading clinical research organization and a leading medical school, bringing together our individual skills and expertise,” said William Roper, dean of the UNC-CH School of Medicine and chief executive officer of UNC Health Care. “We believe this will serve as a model of how a CRO can help an academic medical center increase its efficiency and capacity for effective clinical trials work, and how a medical school can bring added value and expertise to a CRO.”

UNC and Quintiles said they would establish a clinical research unit that would centralize support for research at UNC, and Quintiles will provide training for that group’s staff.

An objective of the alliance is to give patients and investigators access to research, develop clinical investigators, improve efficiency of clinical trials, and enable UNC and Quintiles to collaborate of projects.

“Working with UNC is important for Quintiles because it will provide real benefits for our customers and for patients as well, and it also underscores the innovative research going on at UNC,” said Dennis Gillings, chairman and CEO of Quintiles. “The clinical research unit will help UNC and Quintiles conduct more clinical trials. Drug development always is working against the clock, and I believe this alliance will help us gain precious days and weeks in getting new medicines to patients.”

Quintiles: www.quintiles.com